{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T11:38:54Z","timestamp":1794310734651,"version":"4.9.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ijid.2024.107109","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T16:25:09Z","timestamp":1716395109000},"page":"107109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Comparative effectiveness and safety of six antibiotics in treating MRSA infections: A network meta-analysis"],"prefix":"10.1016","volume":"146","author":[{"given":"Gehang","family":"Ju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaorui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8044-3359","authenticated-orcid":false,"given":"Qi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2024.107109_bib0001","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fcimb.2020.00107","article-title":"Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus","volume":"10","author":"Guo","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"17","key":"10.1016\/j.ijid.2024.107109_bib0002","first-page":"3974","article-title":"Linezolid vs. vancomycin in treatment of methicillin-resistant Staphylococcus aureus infections: a meta-analysis","volume":"21","author":"Li","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ijid.2024.107109_bib0003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jgar.2018.08.014","article-title":"Determinants of methicillin-resistant Staphylococcus aureus (MRSA) prevalence in the Asia-Pacific region: a systematic review and meta-analysis","volume":"16","author":"Lim","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"10.1016\/j.ijid.2024.107109_bib0004","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s40121-021-00456-0","article-title":"Comparative efficacy and safety of vancomycin, linezolid, tedizolid, and daptomycin in treating patients with suspected or proven complicated skin and soft tissue infections: an updated network meta-analysis","volume":"10","author":"Feng","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"4","key":"10.1016\/j.ijid.2024.107109_bib0005","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamainternmed.2019.7495","article-title":"Empirical anti-MRSA vs standard antibiotic therapy and risk of 30-day mortality in patients hospitalized for pneumonia","volume":"180","author":"Jones","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.ijid.2024.107109_bib0006","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41572-021-00259-0","article-title":"Pneumonia","volume":"7","author":"Torres","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.ijid.2024.107109_bib0007","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11739-018-1973-0","article-title":"Risk factors associated with bacteremia correlated with mortality in patients with acute bacterial skin and skin structure infection","volume":"14","author":"Chang","year":"2019","journal-title":"Intern Emerg Med"},{"issue":"4","key":"10.1016\/j.ijid.2024.107109_bib0008","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3390\/pharmaceutics14040714","article-title":"Efficacy and safety of daptomycin versus vancomycin for bacteremia caused by methicillin-resistant Staphylococcus aureus with vancomycin minimum inhibitory concentration >1 \u00b5g\/mL: a systematic review and meta-analysis","volume":"14","author":"Samura","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ijid.2024.107109_bib0009","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13054-017-1801-3","article-title":"Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment","volume":"21","author":"Hassoun","year":"2017","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.ijid.2024.107109_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00041-18","article-title":"Methicillin-resistant Staphylococcus aureus prosthetic valve endocarditis: pathophysiology, epidemiology, clinical presentation, diagnosis, and management","volume":"32","author":"Galar","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.ijid.2024.107109_bib0011","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2024.107109_bib0012","doi-asserted-by":"crossref","first-page":"dlaa114","DOI":"10.1093\/jacamr\/dlaa114","article-title":"Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK","volume":"3","author":"Brown","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.ijid.2024.107109_bib0013","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.2147\/IDR.S340623","article-title":"In vitro activity of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant Staphylococcus aureus isolates collected from Chinese hospitals in 2018-2020","volume":"14","author":"Xu","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijid.2024.107109_bib0014","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4939-9849-4_16","article-title":"Methicillin-resistant Staphylococcus aureus infection and treatment options","volume":"2069","author":"Chalmers","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"8","key":"10.1016\/j.ijid.2024.107109_bib0015","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3390\/antibiotics10081014","article-title":"Daptomycin versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bloodstream infection with or without Endocarditis: a systematic review and meta-analysis","volume":"10","author":"Maraolo","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"9","key":"10.1016\/j.ijid.2024.107109_bib0016","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s10096-013-1867-z","article-title":"Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials","volume":"32","author":"Jiang","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2024.107109_bib0017","article-title":"Linezolid versus vancomycin for skin and soft tissue infections","volume":"2016","author":"Yue","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijid.2024.107109_bib0018","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jgar.2020.12.009","article-title":"Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus","volume":"24","author":"Kato","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"2","key":"10.1016\/j.ijid.2024.107109_bib0019","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Res Synth Methods"},{"issue":"4","key":"10.1016\/j.ijid.2024.107109_bib0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","article-title":"Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.ijid.2024.107109_bib0021","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/14656566.2021.2010706","article-title":"Current pharmacotherapy for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia","volume":"23","author":"Bassetti","year":"2022","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.ijid.2024.107109_bib0022","first-page":"597","article-title":"[Practical guidelines for the management and treatment of infections caused by MRSA, the 2nd Edition]","volume":"88","author":"Niki","year":"2014","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.ijid.2024.107109_bib0023","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2147\/DDDT.S164515","article-title":"Linezolid: a review of its properties, function, and use in critical care","volume":"12","author":"Hashemian","year":"2018","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"10.1016\/j.ijid.2024.107109_bib0024","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jac\/dkw450","article-title":"Linezolid: a promising option in the treatment of Gram-positives","volume":"72","author":"Zahedi Bialvaei","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.ijid.2024.107109_bib0025","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40262-017-0601-x","article-title":"Clinical pharmacokinetics and pharmacodynamics of oxazolidinones","volume":"57","author":"Roger","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijid.2024.107109_bib0026","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","article-title":"Antibiotic penetration into bone and joints: an updated review","volume":"81","author":"Thabit","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2024.107109_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2022.154100","article-title":"Serum linezolid concentrations are reduced in critically ill patients with pulmonary infections: A prospective observational study","volume":"71","author":"Zoller","year":"2022","journal-title":"J Crit Care"},{"issue":"4","key":"10.1016\/j.ijid.2024.107109_bib0028","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0040-1709992","article-title":"Staphylococcus aureus Pneumonia in the Community","volume":"41","author":"He","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ijid.2024.107109_bib0029","doi-asserted-by":"crossref","first-page":"e01619","DOI":"10.1128\/AAC.01619-20","article-title":"Evaluation of linezolid pharmacokinetics in critically Ill obese patients with severe skin and soft tissue infections","volume":"65","author":"Blackman","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2024.107109_bib0030","doi-asserted-by":"crossref","unstructured":"John Jr J. The treatment of resistant staphylococcal infections [version 1; peer review: 3 approved]. F1000Research. 2020;9:150-157. doi:10.12688\/f1000research.17718.1.","DOI":"10.12688\/f1000research.17718.1"},{"issue":"1","key":"10.1016\/j.ijid.2024.107109_bib0031","first-page":"1","article-title":"Difusi\u00f3n de los antibi\u00f3ticos en el sistema nervioso central [Antibiotic diffusion to central nervous system]","volume":"31","author":"Cabrera-Maqueda","year":"2018","journal-title":"Rev Esp Quimioter"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224001802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224001802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T01:31:21Z","timestamp":1723167081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224001802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":31,"alternative-id":["S1201971224001802"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107109","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness and safety of six antibiotics in treating MRSA infections: A network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107109"}}